Nagahata Y, Kondo T, Ono Y, Hiramoto N, et al. High-dose cytarabine chemotherapy (>/=4 g/m(2)/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission. Leuk Lymphoma 2020 Aug 17:1-9. doi: 10.1080/10428194.2020.1805112.
PMID: 32804016